166 related articles for article (PubMed ID: 8671417)
1. Aorto-subclavian thromboembolism: a rare complication associated with moderate ovarian hyperstimulation syndrome.
Germond M; Wirthner D; Thorin D; Ruchat P; Essinger A; De Grandi P
Hum Reprod; 1996 Jun; 11(6):1173-6. PubMed ID: 8671417
[TBL] [Abstract][Full Text] [Related]
2. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
3. Acute cerebrovascular accidents with severe ovarian hyperstimulation syndrome.
El Sadek MM; Amer MK; Fahmy M
Hum Reprod; 1998 Jul; 13(7):1793-5. PubMed ID: 9740425
[TBL] [Abstract][Full Text] [Related]
4. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
5. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
Casper RF
Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408
[No Abstract] [Full Text] [Related]
6. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome].
Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P
Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925
[TBL] [Abstract][Full Text] [Related]
7. Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome.
Kasum M; Orešković S; Franulić D; Čehić E; Lila A; Vujić G; Grgić F
Acta Clin Croat; 2017 Mar; 56(1):133-142. PubMed ID: 29120551
[TBL] [Abstract][Full Text] [Related]
8. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
9. Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome.
Fusi FM; Arnoldi M; Bosisio C; Lombardo G; Ferrario M; Zanga L; Galimberti A; Capitanio E
Gynecol Endocrinol; 2015; 31(9):693-7. PubMed ID: 26527503
[TBL] [Abstract][Full Text] [Related]
10. [Coasting: a response to excessive ovarian stimulation].
Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
[TBL] [Abstract][Full Text] [Related]
11. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
[TBL] [Abstract][Full Text] [Related]
12. Ovarian hyperstimulation: effects of GnRH analogues. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase.
Ben-Arie A; Weissman A; Shoham Z
Hum Reprod; 1996 Jun; 11(6):1146-8. PubMed ID: 8671409
[No Abstract] [Full Text] [Related]
13. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
[TBL] [Abstract][Full Text] [Related]
14. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
Lewit N; Kol S; Manor D; Itskovitz-Eldor J
Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
[TBL] [Abstract][Full Text] [Related]
16. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
[TBL] [Abstract][Full Text] [Related]
17. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome.
Shalev E; Geslevich Y; Ben-Ami M
Hum Reprod; 1994 Mar; 9(3):417-9. PubMed ID: 8006128
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications.
Kol S; Lewit N; Itskovitz-Eldor J
Hum Reprod; 1996 Jun; 11(6):1143-4. PubMed ID: 8671407
[No Abstract] [Full Text] [Related]
19. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A
Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821
[TBL] [Abstract][Full Text] [Related]
20. Ovarian hyperstimulation syndrome and thrombotic events.
Mor YS; Schenker JG
Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
